Abstract
Abnormal T lymphocyte function and reduced interleukin-2 (IL-2) production have been implicated in the pathogenesis of the nephrotic syndrome (NS). We investigated: (1) lymphocyte subpopulations and expression of IL-2 receptor (IL-2R) on T cells using two-colour flow cytometry, (2) serum IL-2 and (3) the soluble component of IL-2R (sIL-2R) in serum, using enzyme-linked immunosorbent assay, in 38 children with NS. All children, except those in remission, had marked proteinuria. They were divided into groups according to renal pathology: (1) steroid-sensitive NS (SSNS) not receiving prednisolone therapy, (2) SSNS on prednisolone, (3) focal segmental glomerulosclerosis (FSGS), (4) SSNS in remission and not receiving prednisolone therapy, (5) congenital NS (CNS). Results were compared with 26 age-matched controls. Total T lymphocytes (CD3) were reduced in groups 1 and 2; CD4 count was reduced in groups 1–4; CD8 count increased in groups 2 and 3; CD8 and CD19 (B lymphocytes) were significantly reduced in group 5. Increased IL-2R expression (CD25) on CD4 lymphocytes was noted in groups 1, 2 and 3 implying activation of these cells. In patients with SSNS, increased serum sIL-2R was recorded during relapse (1,273±497 U/l vs. 913±401 U/l in remission,P<0.005) but free serum IL-2 was not detectable at any stage. The specific alterations in lymphocyte subpopulations in SSNS and FSGS would imply an involvement of the immune system distinct from that in CNS.
Similar content being viewed by others
References
Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet II: 556–559
Fodor P, Saitua MT, Rodriguez Z, Gonzales B, Schlesinger L (1982) T-cell dysfunction in minimal change nephrotic syndrome of childhood. Am J Dis Child 136: 713–717
Taube D, Brown Z, Williams DG (1984) Impaired lymphocyte and suppressor cell function in minimal change nephropathy, membranous nephropathy and focal glomerulosclerosis. Clin Nephrol 22: 176–182
Schnaper HW (1990) A regulatory system for soluble immune response suppressor production in steroid-responsive nephrotic syndrome. Kidney Int 38: 123–128
Kerpen HO, Bhat JG, Kantor R, Gauthier B, Rai KR, Schacht RG, Baldwin DS (1979) Lymphocyte subpopulations in minimal change nephrotic syndrome. Clin Immunol Immunopathol 14: 130–136
Herrod HG, Stapleton FB, Trouy RL, Roy S (1983) Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome. Clin Exp Immunol 52: 581–585
Fiser RT, Arnold WC, Charlton RK, Steele RW, Childress SH, Shirkley B (1991) T-lymphocyte subsets in nephrotic syndrome. Kidney Int 40: 913–916
Gillis S, Ferm MM, Ou W, Smith KA (1978) T cell growth factor: parameters of production and a quantitive microassay for activity. J Immunol 120: 2027–2032
Smith KA (1989) The interleukin 2 receptor. Annu Rev Cell Biol 5: 397–425
Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 113: 619–627
Yorioka N, Hirabayashi A, Kanahara K, Takemasa A, Oda A, Joarder ZH, Yamakido M (1990) Serum soluble interleukin-2 receptor in patients with glomerulonephritis. Am J Nephrol 10: 181–185
Li H-L, Hancock WW, Dowling JP, Atkins RC (1991) Activated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis. Kidney Int 39: 793–798
Mandreoli M, Beltrandi E, Casadei-Maldini M, Mancini R, Zucchelli A, Zucchelli P (1992) Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy. Clin Nephrol 37: 177–182
International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13: 159–165
Cagnoli L, Tabacchi P, Pasquali S, Cenci M, Sasdelli M, Zucchelli P (1982) T cell subset alterations in idiopathic glomerulonephritis. Clin Exp Immunol 50: 70–76
Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, DeBruyere M (1992) Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 13: 215–218
Taylor JMG, Fahey IL, Detels R, Giorgi JV (1989) CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J AIDS 2: 114–124
Fahey JL (1990) Doing it right: measuring T cell subsets by flow cytometry. Clin Immunol Immunopathol 55: 171–172
Giorgi JV, Cheng H-L, Margolick JB, Bauer KD, Ferbas J, Waxdal M, Schmid I, Hultin LE, Jackson AL, Park L, Taylor JMG, Multicentre AIDS Cohort Study Group (1990) Quality control in the flow cytometric measurement of T-lymphocyte subsets: the Multicentre AIDS Cohort Study experience. Clin Immunol Immunopathol 55: 173–186
Laurence J (1993) T-cell subsets in health, infections disease, and idiopathic CD4+ lymphocytopenia. Ann Intern Med 119: 55–62
Fauci AS, Dale DC (1975) Alternate-day prednisolone therapy and human lymphocyte subpopulations. J Clin Invest 55: 22–32
Slade JD, Hepburn B (1983) Prednisone-induced alterations of circulating human lymphocyte subsets. J Lab Clin Med 101: 479–487
Bloemena E, Weinreich S, Schellekens PT (1990) The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo. Clin Exp Immunol 80: 460–466
Hinoshita F, Noma T, Tomura S, Shiigai T, Yata J (1990) Decreased production and responsiveness of interleukin 2 in lymphocytes of patients with nephrotic syndrome. Nephron 54: 122–126
Boumpas DT, Anastassiou ED, Older SA, Tsokos GG, Nelson DL, Balow JE (1991) Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J Clin Invest 87: 1739–1747
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hulton, SA., Shah, V., Byrne, M.R. et al. Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 8, 135–139 (1994). https://doi.org/10.1007/BF00865458
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00865458